Should I Buy KTTA? KTTA 2026 Analysis

Should You Buy Pasithea Therapeutics Corp (KTTA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

0.860

1 Day change

0.82%

52 Week Range

3.850

Analysis Updated At

2026/01/26

Pasithea Therapeutics Corp (KTTA) does not present a compelling buy opportunity for a beginner investor with a long-term strategy at this time. The stock's technical indicators show no strong bullish signals, the financial performance is weak, and there are no recent positive catalysts or significant trading trends to support a purchase. While the analyst rating is positive with a high price target, the company's fundamentals and lack of momentum do not align with the user's investment goals.

Technical Analysis

The MACD is negative and contracting, RSI is neutral at 32.777, and moving averages are converging, indicating no clear trend. The stock is trading near its support level (S1: 0.864), but there is no strong technical signal for a reversal or breakout.

Options Data

Positive Catalysts

Analyst Sara Nik from H.C. Wainwright initiated coverage with a Buy rating and a $3 price target, citing the company's next-generation MEK inhibitor pipeline targeting a $20B potential market.

Neutral/Negative Catalysts

The stock has shown consistent price declines in pre-market, regular market, and post-market trading. Financial performance is weak with no revenue growth, negative net income, and a significant drop in EPS (-85.71% YoY). No recent news or significant trading trends from insiders or hedge funds.

Financial Performance

In Q3 2025, the company reported no revenue growth (0% YoY), a net loss of -$3,037,420 (up 1.25% YoY), and a sharp decline in EPS (-85.71% YoY). Gross margin remains at 0%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

H.C. Wainwright analyst Sara Nik initiated coverage with a Buy rating and a $3 price target, highlighting the company's pipeline as a best-in-class approach to the MAPK pathways and a potential $20B market opportunity.

1 Analyst Rating

Wall Street analysts forecast KTTA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for KTTA is 3 USD with a low forecast of 3 USD and a high forecast of 3 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 0.853

Low

Averages

High

Current: 0.853

Low

Averages

High

H.C. Wainwright

Sara Nik

Buy

initiated

AI Analysis

2025-12-08

Reason